21/09/2023 Alternative Treatments
Tyrosinemia Type 1 (HT-1) is an autosomal recessive genetic condition that impairs the patient's capacity to break down the amino acid tyrosine. This causes a serious build-up of toxic byproducts, causing critical kidney and liver damage in affected patients. Luckily, Nitisinone, a promising treatment of Tyrosinemia type 1 has transformed the treatment of this genetic condition. By blocking an enzyme involved in the breakdown of tyrosine, Nitisinone scales down the accumulation of hazardous substances, preventing organ damage. When used with low-protein foods and other suitable measures, the drug Nitisinone has significantly enhanced the prognosis for patients with HT-1, offering hope and quality of life (QoL).
Pigmentation refers to the coloring of the skin, which is determined by the amount and type of melanin produced in the skin cells. Melanin provides pr...
Hormonal changes significantly influence the development and severity of various types of pigmentation, particularly in women. Hormones such as estrog...
Knee replacement surgery has evolved significantly, offering patients new hope for pain relief and improved mobility. One of the most advanced and eff...
Spending time in the sun is great—until the stubborn tan shows up and refuses to fade. If home remedies and scrubs aren’t cutting it, it’s time to try...
More Details